ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,206,073 | -50.2% | 404,783 | -38.7% | 0.00% | – |
Q2 2023 | $4,432,048 | -29.7% | 660,513 | -7.5% | 0.00% | -100.0% |
Q1 2023 | $6,303,931 | -41.4% | 713,922 | -49.3% | 0.00% | 0.0% |
Q4 2022 | $10,754,751 | +47.9% | 1,407,690 | +37.8% | 0.00% | 0.0% |
Q3 2022 | $7,274,000 | -21.6% | 1,021,461 | -11.0% | 0.00% | 0.0% |
Q2 2022 | $9,282,000 | +31.8% | 1,147,366 | +126.2% | 0.00% | 0.0% |
Q1 2022 | $7,040,000 | -35.9% | 507,254 | +29.5% | 0.00% | 0.0% |
Q4 2021 | $10,989,000 | -30.4% | 391,679 | -15.7% | 0.00% | -50.0% |
Q3 2021 | $15,794,000 | -21.7% | 464,629 | -5.9% | 0.00% | -33.3% |
Q2 2021 | $20,179,000 | -16.0% | 493,823 | -17.3% | 0.00% | -25.0% |
Q1 2021 | $24,027,000 | -4.6% | 596,792 | +40.1% | 0.00% | 0.0% |
Q4 2020 | $25,183,000 | +74.2% | 425,910 | +43.2% | 0.00% | +33.3% |
Q3 2020 | $14,460,000 | +40.0% | 297,346 | +39.2% | 0.00% | +50.0% |
Q2 2020 | $10,330,000 | +65.7% | 213,542 | -4.8% | 0.00% | 0.0% |
Q1 2020 | $6,233,000 | -1.9% | 224,382 | +5.6% | 0.00% | +100.0% |
Q4 2019 | $6,355,000 | +20.2% | 212,389 | +24.1% | 0.00% | 0.0% |
Q3 2019 | $5,289,000 | -27.5% | 171,173 | +13.3% | 0.00% | -50.0% |
Q2 2019 | $7,297,000 | – | 151,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
Triatomic Management LP | 130,805 | $999,350 | 0.84% |
Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |